Stay updated on Tresiba Long-term Use Post-marketing Clinical Trial
Sign up to get notified when there's something new on the Tresiba Long-term Use Post-marketing Clinical Trial page.
Latest updates to the Tresiba Long-term Use Post-marketing Clinical Trial page
- Check6 days agoChange DetectedThe header now shows Revision: v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%
- Check42 days agoChange DetectedRevision: v3.4.3 has been added, replacing Revision: v3.4.2.SummaryDifference0.1%
- Check71 days agoChange DetectedThe page displays Revision: v3.4.2 and removes older notices about funding status and Revision: v3.4.1. These are administrative updates and do not modify the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check78 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page’s revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%
- Check85 days agoChange DetectedThe page adds a 'Show glossary' option. It also updates QC-related metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and the revision reference (Revision: v3.4.0), replacing older labels (Last Update submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.3%
Stay in the know with updates to Tresiba Long-term Use Post-marketing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tresiba Long-term Use Post-marketing Clinical Trial page.